Literature DB >> 9219173

Young Investigator Award presentation at the 13th annual meeting of the ESMRMB, September 1996, Prague. Quantification of pulmonary water compartments by magnetic resonance.

J Lehmann1, J C Böck, P Podrabsky, W Wlodarczyk, R Felix.   

Abstract

The purpose of this study was to quantify pulmonary water compartments of total, intravascular, and extravascular lung water in excised and perfused sheep lungs with the use of magnetic resonance imaging techniques. Total lung water was measured by proton density maps calculated from multi-spin-echo images. Intravascular lung water was evaluated by magnetic resonance angiography before and after injection of gadolinium diethylenetriamine penta-acetic acid polylysine, a macromolecular paramagnetic contrast agent. Intravascular lung water was calculated from signal intensity histogram changes comparing pre- and postcontrast angiograms. Extravascular water was calculated as the difference between total and intravascular lung water. Quantities of total and intravascular lung water measured by magnetic resonance techniques were compared to reference results obtained from wet/dry weight gravimetry and Evans blue dilution performed after imaging. Magnetic resonance and reference results correlated significantly (total lung water: r = 0.93, p < 0.001; intravascular lung water: r = 0.80, p < 0.001; extravascular lung water: r = 0.89, p < 0.001). Therefore, we conclude that quantitative magnetic resonance techniques are potentially useful for the clinical evaluation of pulmonary water compartments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219173     DOI: 10.1007/bf02592259

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  33 in total

1.  Estimation of extravascular lung water by indicator-dilution techniques.

Authors:  F P Chinard
Journal:  Circ Res       Date:  1975-08       Impact factor: 17.367

2.  THE BINDING OF EVANS BLUE TO PLASMA PROTEINS. AN EVALUATION USING ADSORPTION ONTO SEPHADEX.

Authors:  P HANSEN; N C NIELSEN
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

3.  Lung parenchyma: projection reconstruction MR imaging.

Authors:  C J Bergin; J M Pauly; A Macovski
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

4.  Deblurring for non-2D Fourier transform magnetic resonance imaging.

Authors:  D C Noll; J M Pauly; C H Meyer; D G Nishimura; A Macovski
Journal:  Magn Reson Med       Date:  1992-06       Impact factor: 4.668

5.  Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40.

Authors:  Y Berthezène; V Vexler; D C Price; J Wisner-Dupon; M E Moseley; K P Aicher; R C Brasch
Journal:  Invest Radiol       Date:  1992-05       Impact factor: 6.016

6.  Bedside estimation of extravascular lung water in critically ill patients: comparison of the chest radiograph and the thermal dye technique.

Authors:  A Laggner; G Kleinberger; J Haller; K Lenz; G Sommer; W Druml
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

7.  Water proton NMR relaxation mechanisms in lung tissue.

Authors:  M Kveder; I Zupancic; G Lahajnar; R Blinc; D Suput; D C Ailion; K Ganesan; C Goodrich
Journal:  Magn Reson Med       Date:  1988-08       Impact factor: 4.668

8.  Measurement of lung water content and pleural pressure gradient with magnetic resonance imaging.

Authors:  J R Mayo; A L MacKay; K P Whittall; E M Baile; P D Paré
Journal:  J Thorac Imaging       Date:  1995       Impact factor: 3.000

9.  Evaluation of the portable chest roentgenogram for quantitating extravascular lung water in critically ill adults.

Authors:  B D Halperin; T W Feeley; F G Mihm; C Chiles; D F Guthaner; N E Blank
Journal:  Chest       Date:  1985-11       Impact factor: 9.410

10.  Gd-DTPA-polylysine-enhanced pulmonary time-of-flight MR angiography.

Authors:  J C Böck; U Pison; F Kaufmann; R Felix
Journal:  J Magn Reson Imaging       Date:  1994 May-Jun       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.